In contrast to EGF model rats, schizophrenia model mice established by postnatal treatment with neuregulin-1 display a variety of behavioral abnormalities depending on the neuregulin-1 splicing variants administered [79,80]. The gene discussed is EGF; the disease is schizophrenia.